• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝星状细胞作为肝纤维化的关键靶点。

Hepatic stellate cells as key target in liver fibrosis.

机构信息

Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Division of Liver Diseases, Department of Medicine, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, USA; Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.

Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Division of Liver Diseases, Department of Medicine, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.

出版信息

Adv Drug Deliv Rev. 2017 Nov 1;121:27-42. doi: 10.1016/j.addr.2017.05.007. Epub 2017 May 12.

DOI:10.1016/j.addr.2017.05.007
PMID:28506744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5682243/
Abstract

Progressive liver fibrosis, induced by chronic viral and metabolic disorders, leads to more than one million deaths annually via development of cirrhosis, although no antifibrotic therapy has been approved to date. Transdifferentiation (or "activation") of hepatic stellate cells is the major cellular source of matrix protein-secreting myofibroblasts, the major driver of liver fibrogenesis. Paracrine signals from injured epithelial cells, fibrotic tissue microenvironment, immune and systemic metabolic dysregulation, enteric dysbiosis, and hepatitis viral products can directly or indirectly induce stellate cell activation. Dysregulated intracellular signaling, epigenetic changes, and cellular stress response represent candidate targets to deactivate stellate cells by inducing reversion to inactivated state, cellular senescence, apoptosis, and/or clearance by immune cells. Cell type- and target-specific pharmacological intervention to therapeutically induce the deactivation will enable more effective and less toxic precision antifibrotic therapies.

摘要

慢性病毒和代谢紊乱引起的进行性肝纤维化导致每年有超过 100 万人死于肝硬化,但迄今为止尚无批准的抗纤维化疗法。肝星状细胞的转分化(或“激活”)是分泌细胞外基质蛋白的肌成纤维细胞的主要细胞来源,是肝纤维化发生的主要驱动因素。受损的上皮细胞、纤维组织微环境、免疫和全身代谢失调、肠道菌群失调以及肝炎病毒产物的旁分泌信号可以直接或间接诱导星状细胞激活。细胞内信号失调、表观遗传改变和细胞应激反应是通过诱导静止状态的恢复、细胞衰老、细胞凋亡和/或免疫细胞清除来使星状细胞失活的候选靶点。针对特定细胞类型和靶标的药理学干预可以通过诱导失活来进行更有效的、毒性更小的精准抗纤维化治疗。

相似文献

1
Hepatic stellate cells as key target in liver fibrosis.肝星状细胞作为肝纤维化的关键靶点。
Adv Drug Deliv Rev. 2017 Nov 1;121:27-42. doi: 10.1016/j.addr.2017.05.007. Epub 2017 May 12.
2
Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.肝纤维化:是时候针对肝星状细胞的特异性治疗靶点了。
Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):192-197. doi: 10.1016/j.hbpd.2018.04.003. Epub 2018 Apr 21.
3
Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.肝星状细胞中的分子相互作用:细胞凋亡、衰老以及表型逆转作为调节肝纤维化的细胞关联机制
Cell Biol Int. 2017 Sep;41(9):946-959. doi: 10.1002/cbin.10790. Epub 2017 Jul 20.
4
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.刺猬-YAP 信号通路调控谷氨酰胺代谢以控制肝星状细胞的激活。
Gastroenterology. 2018 Apr;154(5):1465-1479.e13. doi: 10.1053/j.gastro.2017.12.022. Epub 2018 Jan 3.
5
Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells.肝纤维化:从基础科学到临床进展,聚焦于肝星状细胞的核心作用。
Int J Mol Sci. 2024 Jul 18;25(14):7873. doi: 10.3390/ijms25147873.
6
Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis.牛磺酸通过抑制自噬和诱导铁死亡来减轻肝星状细胞的激活。
World J Gastroenterol. 2024 Apr 21;30(15):2143-2154. doi: 10.3748/wjg.v30.i15.2143.
7
Hepatic stellate cells role in the course of metabolic disorders development - A molecular overview.肝星状细胞在代谢紊乱发展过程中的作用——分子概述。
Pharmacol Res. 2021 Aug;170:105739. doi: 10.1016/j.phrs.2021.105739. Epub 2021 Jun 23.
8
Autophagy: a multifaceted partner in liver fibrosis.自噬:肝纤维化中一个多面的参与者。
Biomed Res Int. 2014;2014:869390. doi: 10.1155/2014/869390. Epub 2014 Aug 31.
9
Targeting the liver clock improves fibrosis by restoring TGF-β signaling.靶向肝脏生物钟可通过恢复转化生长因子-β信号通路来改善肝纤维化。
J Hepatol. 2025 Jan;82(1):120-133. doi: 10.1016/j.jhep.2024.07.034. Epub 2024 Aug 22.
10
Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.乙酰辅酶 A 羧化酶抑制破坏肝星状细胞激活过程中的代谢重编程。
J Hepatol. 2020 Oct;73(4):896-905. doi: 10.1016/j.jhep.2020.04.037. Epub 2020 May 4.

引用本文的文献

1
M1-BMDMs with Wnt5a deletion attenuate liver fibrosis by suppression of Wnt5a/Frizzled 2 axis in hepatic progenitors.缺失Wnt5a的M1型骨髓来源巨噬细胞通过抑制肝祖细胞中的Wnt5a/卷曲蛋白2轴来减轻肝纤维化。
Cell Biosci. 2025 Aug 30;15(1):125. doi: 10.1186/s13578-025-01467-x.
2
Redefining senescence through hepatocyte fate changes in liver diseases.通过肝脏疾病中肝细胞命运变化重新定义衰老。
Trends Endocrinol Metab. 2025 Aug 28. doi: 10.1016/j.tem.2025.08.003.
3
DC Ameliorates Carbon Tetrachloride-Induced Hepatic Inflammation and Fibrotic Response in Mice.

本文引用的文献

1
3D in vitro models of liver fibrosis.肝纤维化的 3D 体外模型。
Adv Drug Deliv Rev. 2017 Nov 1;121:133-146. doi: 10.1016/j.addr.2017.07.004. Epub 2017 Jul 8.
2
The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.载脂蛋白 L3 基因 I148M 变异可调节人肝星状细胞的纤维生成表型。
Hepatology. 2017 Jun;65(6):1875-1890. doi: 10.1002/hep.29041. Epub 2017 Apr 18.
3
Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
DC改善四氯化碳诱导的小鼠肝脏炎症和纤维化反应。
Pharmaceuticals (Basel). 2025 Aug 20;18(8):1228. doi: 10.3390/ph18081228.
4
Unraveling the Converging Roles of ASC-Dependent Inflammasomes, Interleukin-1 Superfamily Members, Serum Amyloid A, and Non-Sterile Inflammation in Disease Pathology and Fibrosis in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.解析ASC依赖性炎性小体、白细胞介素-1超家族成员、血清淀粉样蛋白A以及非无菌性炎症在炎症性肠病和原发性硬化性胆管炎的疾病病理学和纤维化中的共同作用。
Int J Mol Sci. 2025 Aug 20;26(16):8042. doi: 10.3390/ijms26168042.
5
The Impact of Hybrid Bionanomaterials Based on Gold Nanoparticles on Liver Injury in an Experimental Model of Thioacetamide-Induced Hepatopathy.基于金纳米颗粒的杂化生物纳米材料对硫代乙酰胺诱导的肝病实验模型中肝损伤的影响
Biomolecules. 2025 Jul 24;15(8):1068. doi: 10.3390/biom15081068.
6
The Influence of Irisin on Selected Organs-The Liver, Kidneys, and Lungs: The Role of Physical Exercise.鸢尾素对特定器官——肝脏、肾脏和肺的影响:体育锻炼的作用
Cells. 2025 Aug 8;14(16):1228. doi: 10.3390/cells14161228.
7
The Relationship between the Number of Stem Cells and the Concentration of Stromal Cell-Derived Factor-1 with Disease Severity in Patients with Liver Cirrhosis.肝硬化患者干细胞数量及基质细胞衍生因子-1浓度与疾病严重程度的关系
Int J Hematol Oncol Stem Cell Res. 2025 Apr 1;19(2):158-164. doi: 10.18502/ijhoscr.v19i2.18553.
8
Notoginsenoside R2 attenuates hepatic fibrosis via STAT3-dependent hepatic stellate cells senescence induction and inflammatory microenvironment suppression.三七皂苷R2通过依赖STAT3诱导肝星状细胞衰老和抑制炎症微环境来减轻肝纤维化。
J Ginseng Res. 2025 Sep;49(5):574-584. doi: 10.1016/j.jgr.2025.05.007. Epub 2025 May 30.
9
Endothelial c-Maf prevents MASLD-like liver fibrosis by regulating chromatin accessibility to suppress pathogenic microvascular cell subsets.内皮细胞c-Maf通过调节染色质可及性以抑制致病性微血管细胞亚群,从而预防非酒精性脂肪性肝病样肝纤维化。
JHEP Rep. 2025 Jun 6;7(9):101475. doi: 10.1016/j.jhepr.2025.101475. eCollection 2025 Sep.
10
Risk factor analysis and nomogram development for advanced-stage hepatic fibrosis in patients with Wilson's disease.肝豆状核变性患者晚期肝纤维化的危险因素分析及列线图构建
Front Med (Lausanne). 2025 Jul 30;12:1650584. doi: 10.3389/fmed.2025.1650584. eCollection 2025.
白细胞介素-17A的拮抗作用通过恢复白细胞介素-10/信号转导和转录激活因子3抑制的肝细胞自噬来改善实验性肝纤维化。
Oncotarget. 2017 Feb 7;8(6):9922-9934. doi: 10.18632/oncotarget.14266.
4
Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.自噬通过肝星状细胞中依赖活性氧的Rab25激活来调节脂滴的周转。
Redox Biol. 2017 Apr;11:322-334. doi: 10.1016/j.redox.2016.12.021. Epub 2016 Dec 21.
5
Soluble Egg Antigens of Schistosoma japonicum Induce Senescence of Activated Hepatic Stellate Cells by Activation of the FoxO3a/SKP2/P27 Pathway.日本血吸虫可溶性虫卵抗原通过激活FoxO3a/SKP2/P27信号通路诱导活化肝星状细胞衰老
PLoS Negl Trop Dis. 2016 Dec 30;10(12):e0005268. doi: 10.1371/journal.pntd.0005268. eCollection 2016 Dec.
6
miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway.miR-200a 通过 SIRT1/Notch1 信号通路调控肝星状细胞激活及纤维化。
Inflamm Res. 2017 Apr;66(4):341-352. doi: 10.1007/s00011-016-1020-4. Epub 2016 Dec 26.
7
The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy.未折叠蛋白反应的 XBP1 分支通过自噬诱导肝星状细胞的纤维生成活性。
Sci Rep. 2016 Dec 20;6:39342. doi: 10.1038/srep39342.
8
Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens.Perturb-Seq:通过对汇集基因筛选进行可扩展的单细胞RNA分析来剖析分子回路。
Cell. 2016 Dec 15;167(7):1853-1866.e17. doi: 10.1016/j.cell.2016.11.038.
9
Hepatocyte autotaxin expression promotes liver fibrosis and cancer.肝细胞自分泌运动因子表达促进肝纤维化和肝癌。
Hepatology. 2017 Apr;65(4):1369-1383. doi: 10.1002/hep.28973. Epub 2017 Feb 7.
10
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.通过器官转录组分析和溶血磷脂酸途径抑制实现肝硬化中分子水平的肝癌预防
Cancer Cell. 2016 Dec 12;30(6):879-890. doi: 10.1016/j.ccell.2016.11.004.